IRCT20230930059560N1招募中3 期
Investigating the effect of early montelukast use on the need for hospitalization, duration of hospitalization and clinical symptoms in children aged 2 to 15 years with the diagnosis of Hyperreactiv Airway Disease (HRAD)
Shahre-kord University of Medical Sciences0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 2 years 至 15 years（—）
- 性别
- All
入选标准
- •Children with airway hyperreactivity between 2 years and 15 years who have not recently used systemic or inhaled corticosteroids and are not known to have asthma.
- •Absence of serious diseases that interfere with the research results (such as severe heart or lung diseases).
- •Has not recently used long-term bronchodilators or theophylline.
排除标准
- •patient with known asthma
- •Other diagnoses such as pneumonia are relevant
- •Recent treatment with systemic or inhaled corticosteroids
研究者
相似试验
招募中
2 期
The effect of Montelukast on respiratory complications detected in patients with multiple trauma and lung injuryPulmonary embolismIRCT20190719044270N1Bagheiat-allah University of Medical Sciences60
已完成
3 期
Evaluation of montelukast efficacy on clinical and FEV1/PEFR improvement in acute basthma attackAcute attack asthma.AsthmaIRCT2015092215446N5Vice chanceller for research, Ahvaz Jundishapur University of Medical Sciences80
已完成
4 期
Clinical efficasy of Montelukast-early-intervention for Japanese cedar pollinosisJPRN-UMIN000003105Faculty of Medicine, University of Fukui150
招募中
3 期
The effect of Montecukast on Nephrotic Syndromeephrotic Syndrome.Nephrotic syndromeIRCT20130518013366N13Arak University of Medical Sciences40
招募中
3 期
The effect of Montelukast on COVID 19 disease activityIRCT20181208041886N3Abidi Pharmaceutical company60